Table 1. Baseline characteristics patient and biopsy characteristics.
Overall (N = 13) | |||
---|---|---|---|
Patient Data | |||
Age | 63.0 | (14.9) | |
Female sex | 5 | (41.7%) | |
Biopsy Data | |||
Samples per patient | 1–4 | ||
All samples | 43 | ||
Matching samples | 27 | (62.8%) | |
Location | |||
CET | 18 | (66.7%) | |
Edema | 6 | (22.2%) | |
Tumor-free tissue | 3 | (11.1%) | |
Histopathological Data | |||
CD31 | |||
Absent staining | 8 | (29.6%) | |
Positive staining | 19 | (70.4%) | |
MIB-1 | |||
Absent staining | 3 | (11.1%) | |
Proliferation Index | 14% | (14%) | |
Perfusion Data | |||
wavelet-MRP | |||
CET | 5.58 | (2.74–7.61) | |
Edema | 1.36 | (0.85–5.15) | |
Tumor-free tissue | 3.82 | (3.56–4.12) | |
rCBV | |||
CET | 6.69 | (4.76–9.03) | |
Edema | 3.76 | (1.65–5.52) | |
Tumor-free tissue | 5.04 | (4.44–6.05) |
CET contrast enhancing tissue, wavelet-MRP wavelet-transformed Magnetic Resonance Perfusion, rCBV relative Cerebral Blood Volume